Revenue ($USD) : $2,216,555,000
Revenue (foreign currencies) : CHF2,321,000,000
R&D spend : not available
Employees : 10,400
Fiscal year end : 12/31/22
CEO : Guillaume Daniellot
In May, Straumann announced the full acquisition of GalvoSurge, a Swiss medical device manufacturer in the dental field with a specialization in implant care and maintenance solutions. –CN